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        Both the innate and adaptive immune responses 
are dependent on the migration of leukocytes 
across endothelial cells. Most of this cellular traf-
fi  c, or transendothelial migration (TEM), takes 
place at endothelial cell borders by the process 
of diapedesis, whereby leukocytes squeeze in 
ameboid fashion between the tightly apposed 
endothelial cells (  1  ). Although the surface mole-
cules used by leukocytes and endothelial cells 
during diapedesis have been well characterized, 
the mechanisms by which they regulate this 
process are poorly understood (  1, 2  ). 
  Platelet/endothelial cell adhesion molecule 
1 (PECAM; also known as CD31) is a trans-
membrane glycoprotein expressed on platelets 
and most leukocytes, and concentrated at the 
borders of endothelial cells (  3, 4  ). Homophilic 
interaction between PECAM on the leukocyte 
and PECAM at the endothelial cell border is 
required for diapedesis to occur in vitro and 
in vivo under many, but not all, inflamma-
tory conditions (  5  –  8  ). We recently reported 
that approximately one third of total cellular 
PECAM exists in a membrane reticulum located 
below the surface of the cell at the lateral bor-
ders (  9  ). This membrane reticulum is composed 
of interconnected 50-nm vesicle-like structures 
proximal to and contiguous with the lateral plasma 
membrane. These are distinct from previously 
described vesiculo-vacuolar organelles (  10  ) and 
caveolae (  9  ). In resting endothelial cells, mem-
brane traffi   cs constitutively between the lateral 
cell border and this compartment, which we 
refer to as the lateral border recycling compart-
ment (LBRC), recycling uniformly along the 
lateral border with a t  1/2   of     10 min. However, 
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  Diapedesis of leukocytes across endothelial cells is a crucial step in both the innate and 
adaptive immune responses. Surface molecules on leukocytes and endothelial cells critical 
for diapedesis have been identifi  ed, but the mechanisms underlying this process are not 
understood. Homophilic interaction between platelet/endothelial cell adhesion molecule 
(PECAM) on leukocytes and PECAM at the endothelial border triggers targeted recycling of 
membrane from a reticulum localized close to the endothelial cell lateral border. This 
membrane surrounds the transmigrating leukocyte (Mamdouh, Z., X. Chen, L.M. Pierini, F.R. 
Maxfi  eld, and W.A. Muller. 2003.   Nature  .   421  :748  –  753). How this process occurs and 
whether it is required for diapedesis independent of PECAM are not known. We now report 
that targeted recycling from this lateral border recycling compartment (LBRC) is required 
for diapedesis, is mediated by kinesin family molecular motors, and requires normally 
functioning endothelial microtubules. Selective disruption of microtubules or inhibition of 
kinesin motor domain blocked targeted recycling and diapedesis of monocytes. Further-
more, targeted recycling of membrane from the LBRC was required for transmigration of 
lymphocytes, which migrate independently of PECAM. Thus, traffi  cking of membrane from 
the LBRC to surround leukocytes may be a general requirement for migration of leukocytes 
across the endothelial cell border. Furthermore, these data provide the fi  rst demonstration 
of a role for endothelial microtubules and kinesins in promoting diapedesis, and a mecha-
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min that had leaked across into the collagen was quantifi  ed 
using a fl  uorescent plate reader. There was no signifi  cant dif-
ference in albumin fl  ux across DCN-treated monolayers 
compared with controls (control and DCN = 3,694   ±   787 
and 4,077   ±   104 arbitrary fl  uorescence units, respectively; 
P = 0.24), whereas insudation into bare collagen gels was 
signifi  cantly higher (8,177   ±   193 arbitrary fl  uorescence units; 
P = 9.3   ×   10      5   vs. control; P = 1.4   ×   10      8   vs. DCN). 
Furthermore, DCN treatment did not alter the total ex-
pression of PECAM on the endothelial surface (i.e., at the 
cell borders), as assessed by fl  ow cytometric analysis of iso-
lated cells (  Fig. 1 B  ). 
  Depolymerizing microtubules blocks targeted recycling 
and TEM 
  As described in the previous section, PECAM and VE-cadherin 
localization at cell borders were not aff  ected by DCN treat-
ment. However, TEM was inhibited by 85% when endo-
thelial monolayers were pretreated with 10   μ  M DCN (  Fig. 2 
A  ).   This was not caused by the eff  ects of DCN on monocyte 
adhesion, because adhesion was similar in control and DCN-
treated cells (in a typical experiment, adherence was 48.5   ±   10 
and 46.5   ±   6 monocytes/high power fi  eld for controls and 
DCN-treated monolayers, respectively). The magnitude of 
this block was similar to that observed previously with anti-
PECAM blocking antibodies or soluble PECAM-Fc chimeras 
(  5, 7, 12 ). Indeed, when compared directly with anti-PECAM 
mAb in the same experiment, DCN blocked TEM to the 
same extent as anti-PECAM mAb (  Fig. 2 B  ). Moreover, the 
two treatments were not additive, suggesting that they work 
at the same step in TEM. Control experiments (eluate con-
trol; see Materials and methods for a complete description) 
demonstrated there was no carryover of residual DCN to the 
leukocytes (  Fig. 2 B  ). 
  When we examined recycling from the LBRC during 
monocyte diapedesis, control monolayers showed a bright 
ring-like zone of fl  uorescence representing recycled mem-
brane surrounding monocytes caught in the act of diapedesis, 
as previously described (  9  ). In stark contrast, such enrichment 
was never seen in the DCN-treated monolayers (  Fig. 3  ).   It is 
important to reiterate that the tag used to track recycling 
PECAM is an Fab fragment of a nonblocking antibody 
that does not interfere with any known PECAM function (  6  ). 
It serves merely as a marker for membrane fl  ow from the 
LBRC. DCN treatment did not inhibit adhesion of mono-
cytes to the endothelial cells (see the previous paragraph); mono-
cytes adhered and crawled to the junctions where they 
accumulated but were unable to cross the monolayer (  Fig. 3, 
A and B  , left). 
  We quantifi  ed enrichment of the LBRC at sites of leuko-
cyte  –  endothelial cell interaction in the presence or absence of 
DCN by measuring recycled PECAM fl  uorescence intensity 
(see Materials and methods), as demonstrated in   Fig. 3 C  . In 
contrast to the distinct zones of enrichment of recycling LBRC 
membrane seen around leukocytes in control monolayers, on 
DCN-treated monolayers we usually saw monocytes arrested 
when a neutrophil or monocyte transmigrates across the 
endothelial cell, recycling PECAM-bearing membrane is tar-
geted rapidly and extensively to the site of diapedesis (  9  ). 
Targeted recycling of membrane from the LBRC to surround 
a transmigrating leukocyte requires homophilic PECAM  –
  PECAM interactions at the apical side of the cell border. If this 
interaction is inhibited, both TEM and targeted recycling are 
blocked (  9  ). However, the factors that regulate targeted re-
cycling are not known. 
  Because the structure of the LBRC and its traffi   cking are 
distinct from those of other known endocytic systems, it is 
unclear how the membrane is redirected to surround trans-
migrating leukocytes. Furthermore, it is unclear whether tar-
geted recycling of membrane from this compartment by itself 
is required for transmigration, independent of PECAM. Be-
cause microtubules are involved in directed transport of vesi-
cles over relatively long distances (  11  ), we examined the role 
of microtubules in targeted recycling of membrane from the 
LBRC to sites of diapedesis. Using a nonblocking PECAM 
antibody to mark the recycling compartment, we show that 
membrane from the LBRC is targeted to the site of diapede-
sis in a microtubule-dependent manner. Furthermore, LBRC 
membrane targeting to sites of diapedesis is dependent on 
kinesin-mediated, microtubule-based transport. Depolymer-
ization of microtubules or inhibition of kinesin blocks both 
targeted recycling of membrane from the LBRC and trans-
migration of leukocytes both under conditions in which TEM 
is PECAM dependent and under conditions in which it is 
PECAM independent. 
    RESULTS   
  We fi  rst determined conditions for depolymerizing micro-
tubules in confl  uent endothelial monolayers that had no detect-
able eff  ect on endothelial junctional integrity. We treated 
confl  uent monolayers of human umbilical vein endothelial 
cells (HUVECs) with 10   μ  M of the microtubule-depolymer-
izing drug demecolcine (DCN; also known as colcemide) for 
1 h.   Fig. 1   shows z-series confocal projections of HUVECs 
stained with anti-tubulin and anti-PECAM or anti  –  vascular 
endothelial cell (VE)  –  cadherin antibodies.   Untreated cells show 
well-defi  ned radial arrays of microtubules. In contrast, micro-
tubules were almost completely depolymerized in cells treated 
with DCN, allowing extraction of soluble tubulin monomers 
(  Fig. 1 A  ). The monolayers remained intact and endothelial 
borders were not aff  ected by this treatment, as shown by the 
continuous staining of PECAM and VE-cadherin at the cell 
borders in both control and DCN-treated cells (  Fig. 1 A  ). Thus, 
microtubule disruption does not aff  ect endothelial cell border 
integrity by this criterion. 
  We also examined whether treatment with DCN caused 
a functional change in junctional integrity by measuring the 
permeability of these monolayers to albumin over a time 
course relevant to our experiments. Endothelial monolayers 
were treated with DCN, as described in the previous para-
graph, and incubated with rhodamine-labeled albumin. 
After 1 h, the monolayers were washed briefl  y, and the albu-JEM VOL. 205, April 14, 2008 
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line through the maximum points of intensity along these 
rings (note that this would bias us against fi  nding an inhibi-
tion of LRBC recycling in DCN-treated cells). Even so, en-
richment of recycled membrane increased 12-fold in control 
cells compared with only 2-fold in these selected DCN-
treated cells (  Fig. 3 D  ). These quantitative results are represen-
tative of the qualitative enrichment observed for hundreds of 
over borders between endothelial cells on which the recy-
cling LBRC membrane appeared as a relatively straight line. 
However, sometimes monocytes on DCN-treated monolay-
ers appeared to nestle in the junction, and recycled LBRC 
membrane formed small rings at the interface, presumably 
where homophilic PECAM  –  PECAM interactions were taking 
place. For the purposes of quantitation, we drew our sampling 
    Figure 1.         DCN treatment of HUVECs depolymerizes microtubules without disrupting intercellular junctions or expression of PECAM or VE-
cadherin.   (A) HUVEC monolayers were incubated in the presence of DMSO (vehicle control) or 10   μ  M DCN for 1 h at 37  °  C. Cells were then permeabilized 
to extract soluble tubulin, fi  xed, and stained for PECAM or VE-cadherin and microtubules using Alexa Fluor 546  –  conjugated mAbs against PECAM or VE-
cadherin (red), and for microtubules using anti  –      -tubulin antibody followed by Alexa Fluor 488  –  conjugated secondary antibody (green). Note that this 
prefi  xation permeabilization sometimes removes small portions of membrane, making cell borders appear discontinuous in both control and DCN-treated 
cells (however, see Fig. S1). Bar, 10   μ  m. (B) HUVEC monolayers were treated with DCN or DMSO (Contr) as in A, incubated with fl  uorescently labeled non-
specifi  c antibody (NS) or anti-PECAM mAb, and nonenzymatically resuspended and analyzed by fl  ow cytometry. DCN treatment did not affect the levels 
of surface PECAM at the endothelial borders.     954 LEUKOCYTE TRANSMIGRATION REQUIRES LBRC TRAFFICKING | Mamdouh et al.
  Depolymerizing microtubules has no effect on the size 
or location of the LBRC 
  To test whether DCN treatment aff  ected the organization or 
the location of the LBRC, we examined the morphology of 
the latter in both control and DCN-treated monolayers by 
immunoelectron microscopy (immuno-EM). We labeled the 
LBRC in HUVEC monolayers, as described previously (  9  ), 
and treated the cells with 10   μ  M DCN or DMSO, and pro-
cessed them for immuno-EM. PECAM-containing vesicle-
like structures were seen in proximity to and/or budding 
from the junctions in control as well as in DCN-treated cells 
(  Fig. 4 A  ).   Quantifi  cation of   >  100 cell profi  les revealed no 
diff  erence in the number or the position of these structures in 
the presence or absence of DCN. These data demonstrate 
that the structure and the distribution of the PECAM-con-
taining LBRC near the junction are not aff  ected by micro-
tubule depolymerization. 
  In resting endothelial cells, PECAM-bearing membrane 
is constantly internalized from the cell border into the LBRC 
and cycles back evenly from the LBRC along the lateral 
cell border (  9  ). Although the localization and organization of 
the LBRC were not altered by DCN treatment, it was possi-
ble that defective targeted recycling of this compartment 
was secondary to perturbation of the constitutive recycling 
of the LBRC by microtubule disruption. To determine 
whether constitutive recycling of the LBRC involves micro-
tubules, recycling experiments were performed in control and 
DCN-treated resting endothelial cell monolayers (in the ab-
sence of leukocytes), as described in Materials and methods. 
DCN treatment had no eff  ect on short-distance, constitu-
tive recycling of membrane (  Fig. 4 B  ) from the LBRC. 
Based on these fi  ndings, we propose that the local consti-
tutive recycling of LBRC membrane at cell borders does 
not require microtubules, whereas the targeted recycling 
of membrane from the LBRC to the area of diapedesis is 
  dependent on microtubules. 
  Blockade of targeted recycling and TEM is reversible 
  We tested the eff   ect of another microtubule-destabilizing 
drug, nocodazole, on TEM. Unlike DCN, nocodazole  ’  s ef-
fect on microtubules is rapidly reversible (  13  ). When HU-
VEC monolayers were treated with 2   μ  M nocodazole for 1 h 
at 37  °  C, their microtubules were depolymerized completely 
(Fig. S1, available at http://www.jem.org/cgi/content/full/
jem.20072328/DC1). As with DCN, nocodazole did not 
disrupt the endothelial junctions or the distribution of 
PECAM at the cell borders. Endothelial cells treated with 2   μ  M 
nocodazole or DMSO for 1 h were washed free of drug and 
used in transmigration assays. We quantifi  ed TEM as a func-
tion of time as microtubules recovered (  Fig. 5  ).   Most mono-
cytes crossed the control endothelial monolayer, reaching 
plateau levels (80%) between 30 and 60 min. In contrast, de-
polymerization of endothelial microtubules with nocodazole 
induced a signifi  cant block in monocyte TEM that was over-
come with time after nocodazole washout. TEM in no-
codazole-pretreated cells reached the level of control cells 
leukocyte  –  endothelial cell interactions. Equivalent qualitative 
and quantitative results were seen whether or not the endothelial 
cells had been activated with TNF-    . This block of transmi-
gration, but not of adhesion, and the block in targeted re-
cycling resembled what we previously observed when either 
leukocytes or endothelial cells were blocked with anti-PECAM 
antibodies (  5, 9  ). This strongly suggested that microtubules were 
involved in the targeted recycling of the PECAM-containing 
LBRC, and it demonstrated that targeted recycling of the 
LBRC and TEM could be controlled by factors other than or 
in addition to PECAM interactions at the cell surface. How-
ever, the same eff  ect might be expected if microtubules were 
responsible for maintaining the structure and/or distribution 
of the LBRC. 
    Figure 2.         DCN treatment of endothelial cells blocks transmigra-
tion of monocytes.   (A) Summary of three experiments examining TEM 
across DCN-treated and control (DMSO carrier-treated) endothelial 
cells. DCN inhibition of TEM was signifi  cant (P = 9   ×   10     31  ). Data are 
mean   ±   SEM (  n   = 18; total independent observations across all experi-
ments involving six monolayers and   >  600 monocytes for each variable 
in each experiment). (B) Comparison of the block to TEM afforded by 
DCN and anti-PECAM treatment. These results are combined from three 
independent experiments in which all variables were examined simulta-
neously. HUVEC monolayers were treated (EC Rx) for 1 h with 10   μ  M 
DCN, the equivalent concentration of DMSO carrier, or left untreated (   ), 
and were then washed extensively before monocytes were added for a 
typical TEM assay. DCN treatment blocked TEM to the same degree as 
the blocking anti-PECAM mAb hec7 added to monocytes (Mo Rx). 
The eluate control (DCN-EL; see Materials and methods) showed that 
there was no carryover of DCN treatment to affect monocytes. Data 
shown are mean for all three experiments   ±   SEM (  n   = 6 per condition 
for each independent experiment). All inhibitions by hec7 or DCN were 
signifi  cantly different from all controls. P   ≤   0.00031 using the Bonfer-
roni correction.     JEM VOL. 205, April 14, 2008 
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of trace amounts of nocodazole in the collagen matrix. How-
ever, there was clearly no signifi  cant carryover of the drug 
to the leukocytes, as shown by the eluate control (  Fig. 5  , 
top), demonstrating that the eff  ect of nocodazole seen on 
monocyte TEM is a result of depolymerization of endothelial 
cell microtubules. 
by 90 min. Recovery of monocyte TEM after nocodazole 
washout was concomitant with microtubule repolymeriza-
tion (  Fig. 5  , bottom). Recovery of microtubules after no-
codazole washout in endothelial cells grown on collagen gels 
was slower than recovery of the same cells grown on fi  bronectin-
coated plastic (10  –  15 min) and was likely caused by retention 
    Figure 3.         Microtubules are crucial for targeted recycling of PECAM-containing LBRC.   HUVEC monolayers were prepared for visualization of 
targeted recycling of PECAM, treated with DCN or diluent control (see Materials and methods), and incubated with monocytes. Recycling PECAM was 
visualized with rhodamine-conjugated goat anti  –  mouse F(ab   ) 2  , monocytes with Alexa Fluor 488  –  labeled anti-CD11b. (A) Representative low-power fi  elds. 
(B) High-power fi  elds to demonstrate enrichment of recycled PECAM around transmigrating leukocytes. (left) Overlay of the recycled PECAM and CD11b 
fl  uorescence channels. (right) Recycled PECAM channel only. Arrows point to representative monocytes. Insets in B show orthogonal views of the mono-
cytes transmigrating in control cells and unable to transmigrate in the DCN-treated cells. The thin white line outlines the endothelial monolayer. Targeted 
recycling was seen around control monocytes that transmigrated but was not seen around monocytes at the borders between DCN-treated cells, where 
transmigration was inhibited. Bars, 10   μ  m. (C) Illustration of the procedure for quantifi  cation of enrichment of membrane recycling from the LBRC (see 
Materials and methods). Pixel intensity was quantifi  ed along the lines shown, drawn to include the endothelial border at the site of leukocyte interaction 
and away from it. Gray levels are graphed to the right of each picture. The numbers on the fl  uorescence micrograph (arrows) correspond to positions 
along the line indicated on the x axis. Two monocytes are transmigrating between approximately positions 60  –  90 and 105  –  125 in the control sample, and 
one monocyte is arrested at the junction between positions 50  –  85 in the DCN sample. (D) Quantifi  cation of maximal enrichment values   ±   SD for 14 (con-
trol) and 15 (DCN) junctions, as illustrated in C and described in Materials and methods. Enrichment is signifi  cantly greater in controls (P = 2   ×   10     7 ).   956 LEUKOCYTE TRANSMIGRATION REQUIRES LBRC TRAFFICKING | Mamdouh et al.
monolayers but blocked monocyte TEM by 90% (Fig. S3). 
Similar to DCN-treated cells, targeted recycling of PECAM 
was blocked in taxol-treated cells (unpublished data). Further-
more, as with DCN (  Fig. 4  ), taxol treatment did not have any 
eff  ect on constitutive recycling of the LBRC (Fig. S4). 
  Of interest, stabilizing actin fi  laments in endothelial cells 
with the drug jasplakinolide had a very modest, if any, ef-
fect on transmigration (Fig. S3). This suggests that dynamic 
changes in actin fi  laments are not involved in targeted re-
cycling of the LBRC. We were unable to eff  ectively depoly-
merize actin fi  laments without compromising the integrity 
of the monolayer, so we were unable to perform the con-
verse experiment. 
  Microtubule depolymerization has been shown to induce 
perinuclear clustering of mitochondria in several cell types. 
This raised the possibility that inhibition of TEM by micro-
tubule-depolymerizing agents might be caused by deprava-
tion of a local source of concentrated ATP necessary to 
support diapedesis. Migrating lymphocytes require polarized 
mitochondria for chemotaxis (  15  ). However, direct observation 
of mitochondria in DCN-treated cells showed that perinuclear 
collapse of mitochondria required overnight drug treatment, 
  Specifi  city of drug effects on microtubules 
  Although DCN and nocodazole are believed to be selective 
microtubule agonists, no drug is completely specifi  c; micro-
tubule depolymerization with these types of inhibitors may 
also aff  ect rho GTPases, myosin light chain kinase, and others, 
causing changes in the distribution of actin and intermediate 
fi  laments and redistribution of organelles. We therefore per-
formed a series of experiments to determine whether the block 
in TEM could be caused by these secondary eff  ects. 
  The drug taxol, a microtubule agonist, is not known to 
have these side eff  ects. It stabilizes microtubules and results 
in accumulation of noncentrosomally organized microtu-
bule bundles in many cell types (  14  ). To determine whether 
interfering with normal microtubule function in this man-
ner also aff  ected TEM, we incubated endothelial cells for 
1 h with 10   μ  M taxol. This treatment induced bundling 
of microtubules without altering the endothelial junctions 
(Fig. S2 A, available at http://www.jem.org/cgi/content/
full/jem.20072328/DC1). The effi   cacy of taxol treatment was 
demonstrated by the resistance of microtubules in treated 
ECs to cold-induced depolymerization (Fig. S2 B). Taxol treat-
ment had no eff  ect on monocyte adhesion to endothelial 
    Figure 4.         Depolymerization of microtubules does not affect the morphology, localization, or constitutive recycling of the PECAM-containing 
LBRC.   (A) HUVEC monolayers were incubated in the presence of HRP-labeled nonblocking anti-PECAM IgG to saturably label PECAM at the cell bor-
ders and in the LBRC before addition of DCN, as described in Materials and methods, and processed for immuno-EM. En face sections of DCN-treated 
cells show the same morphology and localization of PECAM-containing LBRC (arrows) as control cells. Analysis showed 9.8   ±   3.4 (mean   ±   SD) vesicles/  μ  m 
in control cells versus 8.9   ±   2.2 vesicles/  μ  m in DCN-treated cells (differences not signifi  cant). Bar, 200 nm. (B) Quantitative LBRC recycling experiments 
were performed on control (continuous line) and DCN-treated HUVEC monolayers (dotted line) in the absence of leukocyte diapedesis, as described in 
Materials and methods. Pixel intensity at the cell junctions was quantifi  ed from digitized images acquired at each time point. Data shown are mean   ±   SEM 
of at least 20 fi  elds acquired from each of two replicates per time point. The experiment was repeated three times with similar results. No signifi  cant 
differences were observed.     JEM VOL. 205, April 14, 2008 
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calcium signaling (  16  ) that is required for TEM (  17  ). How-
ever, treatment of HUVEC monolayers with DCN under the 
conditions used for our TEM experiments had no eff  ect on the 
distribution of endoplasmic reticulum (Fig. S5 B). 
  Furthermore, we directly tested the eff  ect of this DCN 
treatment on endothelial calcium signaling in response to 
10   μ  M histamine, which produces a similar increase in cyto-
solic free calcium (  ↑  [Ca  +2  ]  i  ) to that of leukocyte  –  endothelial 
cell interactions (  17  ). There was no signifi  cant diff  erence 
in the responses of control and DCN-treated endothelial 
whereas mitochondria remained at the cell periphery during 
the 1-h treatment we used to block targeted recycling and 
TEM (Fig. S5 A, available at http://www.jem.org/cgi/content/
full/jem.20072328/DC1). Additionally, mitochondria re-
main peripherally distributed in the taxol-treated cells, which 
do not support TEM. Thus, changes in mitochondrial distri-
bution are not the reason for nocodazole or DCN-induced 
inhibition of TEM and targeted recycling. 
  Similarly, disrupting microtubules can cause centripetal 
redistribution of the endoplasmic reticulum, which may aff  ect 
    Figure 5.         The effect of microtubule-depolymerizing drugs on monocyte TEM is reversible.   HUVEC monolayers were incubated in 2   μ  M no-
codazole or diluent control for 60 min at 37  °  C. After extensive washing, freshly isolated PBMCs were added on the top of both control and nocodazole-
treated HUVEC monolayers, and the co-cultures were incubated for different time periods at 37  °  C. A replicate set of monocytes was resuspended in 
conditioned medium from nocodazole-treated HUVEC monolayers (eluate) to control for carryover of nocodazole (see Materials and methods). After 
washing and fi  xing the cells, monocyte TEM was quantifi  ed (top), and microtubule morphology (bottom) was examined at each time point. Data are mean   ±   
SEM for six to eight random fi  elds on each of fi  ve replicates per time point. Nocodazole treatment signifi  cantly reduced transmigration at 60 and 90 min 
(P = 0.0021 and 0.0056, respectively) but not at 120 min (P = 0.63). The experiment was repeated three times with similar results. The bottom panels 
show microtubules stained in green and total PECAM stained in red. These monolayers were not extracted to remove soluble tubulin, which stains in an 
amorphous and partially reticular pattern in the cytoplasm at time zero, as it is dispersed between other organelles. Note that monolayers remain intact, 
as assessed by maintenance of peripheral PECAM staining, and there is progressive recovery and centrifugal growth of microtubules as a function of time. 
Because peripheral microtubules sometimes obscure PECAM staining in the merged images, insets show the PECAM channel of the same fi  eld at a lower 
magnifi  cation. Numbers show the time in minutes after nocodazole washout. Bar, 10   μ  m.     958 LEUKOCYTE TRANSMIGRATION REQUIRES LBRC TRAFFICKING | Mamdouh et al.
cells (Fig. S5 D). In all of these experiments, staining for 
    -tubulin demonstrated that the DCN treatment eff  ectively 
depolymerized microtubules. 
  Microtubules are also required for PECAM-independent 
transmigration 
  Inhibition of PECAM function and of microtubule integ-
rity resulted in the same phenotype: leukocytes blocked at 
the apical surface of the endothelial cell border without tar-
geted recycling from the LBRC. However, we were in-
terested to know whether this was a general phenomenon, 
and in particular, whether PECAM-independent transmi-
gration also depended on intact microtubules and traffi   cking 
from the LBRC. Polyclonally activated human T cells trans-
migrate our cytokine-activated HUVEC monolayers in rea-
sonable numbers. Unlike transmigration of monocytes and 
neutrophils, activated lymphocyte migration cannot be sig-
nifi  cantly inhibited by anti-PECAM blocking mAbs (un-
published data) (  18, 19  ). We examined transmigration of 
monocytes and lymphocytes across TNF-      –  activated HU-
VEC monolayers treated with DCN to depolymerize micro-
tubules. Transmigration of both cell types was markedly 
reduced on the DCN-treated monolayers (  Fig. 6 A  ).   As usual, 
the eluate control demonstrated that the eff  ect of DCN 
was only on the endothelial cells. Moreover, targeted re-
cycling from the LBRC was seen around T cells transmi-
grating control monolayers but not around those stuck at 
the junctions of DCN-treated monolayers (  Fig. 6 B  ). Thus, 
leukocyte transmigration requires intact endothelial micro-
tubules regardless of whether it requires PECAM. 
  Targeted recycling and TEM require kinesin family 
molecular motors 
  The preceding data support the idea that intact microtubules 
are essential for leukocyte TEM by bringing the LBRC to 
the site of diapedesis. Because the kinesin family of micro-
tubule motors can transport vesicles toward microtubule plus 
ends (toward the periphery of endothelial cells; for review see 
reference   11  ), we next explored whether kinesin-mediated 
transport was involved in the targeted traffi   cking  of  the 
LBRC to the site of TEM. Of the 41 known human kinesin 
family members, 30 are expressed at the mRNA or protein 
level in HUVECs (Table S1, available at http://www.jem
.org/cgi/content/full/jem.20072328/DC1). This rendered 
attempts to reduce their levels singly and in combination by 
methods such as RNA interference impractical. Instead, we 
chose to inhibit kinesin activity directly by microinjection 
of HUVEC monolayers with a function-blocking antibody, 
known as HD, that was raised against the highly conserved 
motor domain of   Drosophila   kinesin heavy chain (  20  ). Immuno-
blot analysis and functional studies suggest that HD recog-
nizes several kinesin family members in addition to KIF5 
(conventional kinesin) (  21  ) and, thus, could likely inhibit mul-
tiple kinesin family members in HUVECs. 
  The organization of mitochondria is dependent on micro-
tubules and kinesins (  22  –  24  ). In addition, microinjected HD 
    Figure 6.         Intact microtubules are required for transmigration of 
lymphocytes.   (A) HUVEC monolayers were activated with TNF-    , as de-
scribed in Materials and methods, and treated or not with DCN before the 
addition of monocytes or polyclonally activated cultured T cells. Transmi-
gration was allowed to proceed for 1 h. One set of leukocytes was re-
suspended in conditioned medium washed out of DCN-treated HUVECs 
(eluate) as a control for DCN carryover, and then added to the endothelial 
cells. Data shown are mean   ±   SD for eight observations per sample. Trans-
migration across DCN-treated monolayers is signifi  cantly inhibited com-
pared with controls for both monocytes and lymphocytes (P = 1.2   ×   10     12  
and 5.5   ×   10     4  , respectively, using the Bonferroni correction). (B) Rep-
resentative images from a typical experiment demonstrating that targeted 
recycling of LBRC membrane is inhibited in DCN-treated endothelial 
monolayers. Recycled PECAM was visualized as in the previous fi  gures; 
lymphocytes were visualized with fl  uorescent CD11a (green). Merged 
  images show enrichment of recycling LBRC membrane around trans-
migrating lymphocytes on control but not DCN-treated endothelium 
(see legend to   Fig. 3  ).     JEM VOL. 205, April 14, 2008 
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merized after washout of nocodazole. In cells injected with 
HD IgG, mitochondria remained centrally located, whereas 
mitochondria in cells injected with the same concentration 
of normal rabbit IgG moved out to the cell periphery and 
within 1 h resembled untreated cells (Fig. S6). Thus, injected 
HD is able to block a known kinesin function in endothelial 
cells. Note, however, that although HD IgG prevented the 
centrifugal redistribution of previously collapsed mitochon-
dria, there was no signifi  cant eff  ect on redistribution of 
IgG was previously shown to alter the distribution of mito-
chondria (  23  ). Thus, as a test of HD effi   cacy in endothelial 
cells, we fi  rst examined whether it inhibited centrifugal re-
distribution of mitochondria after washout of microtubule 
antagonists in endothelial cells. We fi  rst induced perinuclear 
accumulation of microtubules with nocodazole, and then 
injected HD or control rabbit IgG, washed out the nocodazole, 
and monitored the redistribution of microtubules and mito-
chondria. In both sets of cells, microtubules rapidly repoly-
    Figure 7.         Blocking kinesin motor domain has no effect on PECAM or ICAM-1 expression, nor on distribution of microtubules.   (A)  TNF-   –
  stimulated HUVECs injected with HD IgG were incubated for 6 h and stained for PECAM or ICAM-1 expression. Alexa Fluor 546  –  labeled goat anti  –  rabbit 
IgG was used to visualize injected cells. No difference in expression was seen between injected and uninjected cells. Bar, 10   μ  m. (B) HUVECs treated and 
microinjected with HD or control IgG as in A were washed and fi  xed in methanol and stained to visualize microtubules (green) or to visualize injected 
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transmigration and is critical for leukocytes to complete dia-
pedesis (  12  ). Several other molecules of the endothelial junc-
tion, including ICAM-2, junctional adhesion molecule A, 
endothelial cell  –  selective adhesion molecule, and poliovirus 
receptor, have been implicated in diapedesis (  25  –  28  ). As with 
PECAM and CD99, evidence for the involvement of these 
molecules comes from blocking experiments in vitro and an-
tibody blocking or genetic ablation experiments in vivo. These 
studies demonstrate a necessary role for these molecules in 
diapedesis. However, the mechanisms through which these 
molecules regulate diapedesis are still largely unknown. 
  Insights into the mechanism began to unfold when we 
reported that     30% of the total endothelial cell PECAM was 
present in the LBRC, a reticulum of vesicle-like structures 
connected to each other and to the surface of the cell at the 
intercellular borders (  9  ). Although this membrane recycled 
  mitochondria over the time course of our experiments 
when injected into untreated cells (not depicted), similar to 
the lack of eff  ect of DCN on mitochondrial distribution 
(Fig. S5 A). Furthermore, microinjection of control or HD 
IgG had no eff  ect on the distribution of intermediate fi  la-
ments, as assessed by vimentin staining (Fig. S5 C). 
  Important for our next series of experiments, micro-
injection of endothelial cells with HD antibody had no eff  ect 
on the expression or distribution of intercellular adhesion 
molecule (ICAM) 1 or PECAM (  Fig. 7 A  ), or of microtubules 
(  Fig. 7 B  ).   To demonstrate this,   Fig. 7   intentionally shows 
fi  elds in which some cells are uninjected and in which in-
jected cells contain diff  erent amounts of antibody for direct 
comparison. We performed TEM experiments on mono-
layers in which large patches of adjacent endothelial cells were 
injected with HD or control antibodies. After the assay, mono-
layers were fi  xed and stained to identify the injected endo-
thelial cells and examined by confocal microscopy to assess 
adhesion and transmigration. There was no signifi  cant diff  er-
ence in the adhesion of monocytes to endothelial cells injected 
with HD IgG compared with control antibody (  Fig. 8 A  ).   
However, TEM was decreased by   >  80% across cells injected 
with the anti-kinesin motor domain antibody compared with 
cells injected with control antibody (  Fig. 8 B  ). 
  When we examined targeted recycling of the LBRC in 
these experiments, we found that the compartment recycled 
to surround leukocytes transmigrating across uninjected or 
control IgG  –  injected endothelial cells, as expected (  Fig. 9  ).   
However, although leukocytes could adhere normally to the 
surfaces of endothelial cells injected with HD IgG (  Fig. 8 A  ) 
and crawl to the intercellular borders, targeted recycling to 
the vicinity of leukocytes adherent to these cells was not ob-
served (  Fig. 9  ). Leukocytes remained adherent to the apical 
surface of the endothelium straddling the junction, whereas 
membrane from the LBRC recycled evenly along the bor-
ders without enrichment at points of leukocyte  –  endothelial 
cell contact. These co-cultures resembled those in which mi-
crotubules were depolymerized with DCN (  Fig. 3  ) or blocked 
with anti-PECAM mAb (  9  ). However, in these cells micro-
tubules were intact and PECAM was unperturbed. We con-
clude that targeted recycling from the LBRC to the site of 
diapedesis is required for TEM, and that this requires both 
intact microtubules and functional kinesin, presumably for 
kinesin-mediated movement of LBRC membrane along in-
tact microtubules. 
    DISCUSSION   
  Our knowledge of the molecules involved in diapedesis has 
increased dramatically in the past 15 yr. PECAM was the fi  rst 
molecule demonstrated to play a unique role in diapedesis 
unrelated to leukocyte  –  endothelial cell adhesion. Homo-
philic interaction between PECAM on the leukocyte and 
PECAM concentrated at the endothelial cell border is critical 
for diapedesis of adherent leukocytes to proceed (  5  ). A similar 
homophilic interaction between leukocyte CD99 and CD99 
concentrated at the endothelial border controls a later step in 
    Figure 8.         Blocking kinesin motor domain selectively blocks TEM.  
(A) HUVECs activated for 4 h with TNF-     and injected with HD or control 
IgG were incubated with monocytes. The total number of monocytes ad-
herent to endothelial cells injected with control or anti-kinesin antibody 
was quantifi  ed from observations of hundreds of leukocytes interacting 
with endothelial cells in at least 16 random fi  elds from three replicate 
dishes. Data are expressed as adhesions per fi  eld (including uninjected and 
injected cells) or as adhesion to injected (inj) cells only. Data are mean   ±   
SEM. The small apparent difference in adhesion is not statistically signifi  -
cant. (B) Monocytes in the experiment shown in A were further analyzed 
for TEM. The percentage of adherent monocytes that migrated across the 
endothelial monolayer is shown as the mean   ±   SEM for the same number 
of fi  elds and replicates. Anti-kinesin antibody blocked transmigration by 
  >  80% (P = 0.00386). These results are representative of three independent 
experiments. 602 monocytes were counted for control monolayers and 
271 were counted for HD-injected monolayers, interacting with 305 HUVECs 
injected with control IgG and 163 HUVECs injected with HD.     JEM VOL. 205, April 14, 2008 
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known endocytic vesicular systems and not even composed 
of true vesicles, because the compartment is never sealed off   
completely from the junctional surface (  9  ). Thus, it was not 
clear how traffi   cking of this membrane would occur. We re-
port in this paper that targeted recycling of membrane from 
the LBRC to the site of diapedesis requires intact and normally 
functioning microtubules and active kinesin motors. Al-
though we are unable to visualize this directly, the most logi-
cal mechanism would be that LBRC membrane is moved 
along microtubules to the site of diapedesis by kinesin. Dis-
rupting microtubules (  Figs. 2, 3, and 5  ; and Fig. S3) or inter-
fering with kinesins ( Figs. 8 and 9 ) blocked diapedesis without 
aff  ecting the local, constitutive recycling of PECAM from 
the LBRC or the adhesion of leukocytes. The phenotype of 
the arrested cells resembled that seen when homophilic inter-
actions of leukocyte and endothelial cell PECAM were in-
hibited using blocking antibodies ( 9  ). However, in the present 
study, no PECAM function  –  blocking reagents were neces-
sary to disrupt targeted recycling and diapedesis. The fact that 
depolymerization of endothelial microtubules, inhibition of 
rapidly and evenly between the junctional surface and the 
LBRC in resting endothelial cells, during diapedesis, this 
membrane traffi   cking was redirected to the site on the endo-
thelial cell border where the leukocyte was in the process of 
transmigrating. Although we see a clear enrichment of fl  uo-
rescence representing recycling membrane traffi   cking to the 
transmigration zone, we have not seen the three dimensional 
  “  docking sites  ”   or   “  transmigratory cups  ”   described by Barreiro 
et al. (  29  ) and Carman et al. (  30  ). Such structures were also not 
seen by other investigators (  31  ) studying diapedesis in vitro  .   
Diff  erences in our results are likely caused by diff  erences in the 
experimental systems used. Homophilic interaction between 
leukocyte and endothelial PECAM triggered this targeted 
recycling (  9  ), and TEM was not observed in the absence of 
targeted recycling. However, it was unclear whether this re-
cycling by itself was required for TEM or whether this phe-
nomenon was independent of PECAM. 
  This raised the question of how membrane from the LBRC 
is targeted to the zone of leukocyte diapedesis. The LBRC ap-
pears to be a unique organelle, organized diff  erently from 
    Figure 9.         Blocking kinesin motor domain blocks targeted recycling of membrane from the LBRC.   Cytokine-activated endothelial cells were 
  microinjected with nonimmune rabbit IgG (control) or HD IgG and used in targeted recycling experiments, as described in Materials and methods. Each of 
the top two rows shows the same representative fi  eld of z-series projections of confocal images. Individual panels show monochrome images of the loca-
tion of injected antibody (far red, displayed as white), recycled PECAM (red), and monocytes stained with anti-CD11b (green). The far right panels show 
merged images of recycled PECAM and CD11b; the bottom panels show an orthogonal (X-Z) projection through the stacks along the line indicated in 
white. Note that although transmigration and targeted recycling occurred normally in cells injected with nonimmune IgG (XZ1), transmigration and tar-
geted recycling of membrane from the LBRC were blocked in cells injected with the HD antibody (XZ2), and membrane recycled evenly along the intercel-
lular border. The fl  uorescence intensity of recycled PECAM along the line drawn clockwise around the transmigrating monocyte (indicated by a large 
arrow) for control IgG and along a line drawn through the center of the rectangle for HD (not depicted, so as not to obscure the original data) are 
graphed below the micrographs. Numbers on micrographs (small arrows) correspond to the position along the measured line, as in  Fig.  3 .  Bar,  10   μ m.   962 LEUKOCYTE TRANSMIGRATION REQUIRES LBRC TRAFFICKING | Mamdouh et al.
  We studied TEM in the absence of fl  uid shear in our as-
says. Unfortunately, performing these assays under fl  ow is not 
technically feasible at this time. Endothelial cells grown on 
collagen gels cannot be microinjected or used in available 
perfusion chambers. Endothelial cells grown on glass cover-
slips (as they would be for standard fl  ow chamber systems) do 
not make a physiological basement membrane, as they do on 
collagen gels, and thus, do not adhere to the substrate as tightly. 
When treated with DCN, they lift off   in large patches when 
subjected to shear fl  ow. However, everything that we have 
published using our static transmigration system in vitro has 
been borne out in vivo. This includes the role of Mac-1 in 
locomotion (  32, 33  ), roles for PECAM (  5, 7, 8  ) and CD99 
(  12, 34, 35  ) in transmigration (but not adhesion), and the ef-
fects of prolonged (days) culture of transmigrated monocytes 
in our system on their diff  erentiation into immature dendritic 
cells and monocytes (  36, 37  ). Furthermore, studies on the 
transmigration of myeloid cells show that fl  ow may increase 
the rate of transmigration quantitatively but does not change 
any aspects qualitatively (  38, 39  ). 
  Vesicles similar to the LBRC exist in vivo (unpublished 
data), but it is not possible to study targeted recycling in vivo 
with our current markers. We hope that isolation of the LBRC 
compartment by subcellular fractionation will lead to the 
identifi  cation of unique markers for the LBRC that are suit-
able for use in vivo. 
  Although it is clear that targeted recycling from the 
LBRC is critical for diapedesis, the function served by this pro-
cess is not known. Targeted recycling would be expected to 
increase the membrane surface area at the cell border, thus 
facilitating leukocyte passage without the need for endothe-
lial retraction. Moreover, although PECAM, CD99, and VE-
cadherin are all internalized from the endothelial cell border 
(  9  ), only PECAM and CD99 appear to be part of the LBRC 
(unpublished data). VE-cadherin along the cell border tempo-
rarily moves out of the way as leukocytes transmigrate (  40, 41  ). 
One scenario to explain these observations is that LBRC mem-
brane (containing PECAM and CD99, but not VE-cadherin) 
targeted to surround the leukocyte physically displaces the 
junctional membrane rich in VE-cadherin, thus creating a 
temporary zone for transmigration without disrupting com-
plex junctional structures. Alternatively, VE-cadherin may be 
internalized into a separate vacuolar compartment. 
  Homophilic interaction of PECAM and CD99 on leuko-
cytes with the same molecules at the endothelial cell border 
is necessary for transmigration. However, at the endothelial 
cell border, these molecules are already engaged in homo-
philic interactions with the same molecules on the apposing 
endothelial cell. Another potential function of LBRC traf-
fi  cking could be to bring unligated PECAM, CD99, and/or 
other components of the LBRC into contact with their ligands 
on leukocytes to initiate and propagate the signals for further 
recruitment of this membrane farther along the junction as 
the leukocyte moves through. Alternatively, or additionally, 
the accretion of free PECAM-bearing (or other components 
of the LBRC) membrane in the vicinity of the leukocyte 
kinesin motor function, and blockade of PECAM function 
by antibody inhibited TEM to the same extent (  Figs. 2 and 8  ) 
and were not additive (  Fig. 2  ) suggests that these perturba-
tions block TEM along the same functional pathway. For the 
same reason, we hypothesize that blockade of PECAM func-
tion by antibodies and inhibition of kinesin motors by HD 
would not be additive, but we have not tested this. Although 
we cannot rule out additional roles of microtubules and kine-
sin molecular motors in TEM, we propose that homophilic 
engagement of leukocyte PECAM with endothelial PECAM 
at the apical surface of the endothelial cell border sends a signal 
that triggers recruitment of membrane from the LBRC to the 
site of diapedesis, and that this targeted recruitment requires 
  kinesin-mediated, microtubule-based transport. Of course, other 
molecules at the endothelial border and/or in the LBRC may 
participate in this signaling process downstream of PECAM. 
Similarly, even though the ability of endothelial cells to fl  ux 
cytosolic-free calcium was not aff  ected by dissolution of micro-
tubules under our experimental conditions, this does not mean 
that calcium signaling may not play a role in the targeted re-
cycling of LBRC membrane. Our data also demonstrate that 
targeted membrane recycling from the LBRC is itself required 
for diapedesis, because inhibiting targeted recycling indepen-
dently of PECAM blocked diapedesis eff  ectively. 
  TEM was rarely observed across endothelial cells injected 
with the function-blocking anti-kinesin antibody HD. In fact, 
in those cultures, monocytes appeared to transmigrate in high 
numbers across uninjected endothelial cells at the borders of 
the injected patches (unpublished data). Adherent leukocytes 
that cannot transmigrate because PECAM is blocked crawl 
along the junctions of endothelial monolayers, from endo-
thelial cell to endothelial cell, as if searching for a place to dia-
pedese (  32  ). The extra monocytes that did transmigrate across 
the uninjected endothelial cells adjacent to the HD-injected 
ones likely represent leukocytes that were unable to transmi-
grate the HD-injected endothelial cells and crawled across the 
monolayer until they came to uninjected cells. This behavior 
was not seen in cells injected with control antibody. 
  The fact that stabilization of microtubules with taxol also 
selectively blocked TEM (Figs. S2  –  S4) suggests that dynamic 
rather than static microtubules may be necessary for targeted re-
cycling from the LBRC. Given the technical limitations of our 
experimental system, we are unable to directly visualize recy-
cling LBRC membrane moving along microtubules in living 
cells. Thus, we cannot completely rule out the possibility that 
microtubules and kinesin motors serve as an anchoring platform 
for targeted recycling rather than acting to actively transport 
vesicles. However, the fact that taxol, which would not be ex-
pected to alter such a scaff  olding structure, also blocked targeted 
recycling and transmigration would argue against this. Neither 
taxol nor the microtubule-depolymerizing drugs had a detect-
able eff  ect on the structure of the LBRC or kinetics of constitu-
tive recycling. We hypothesize that constitutive recycling of 
this compartment may be governed by myosin motors on actin 
fi  laments, but the regulation and purpose of constitutive re-
cycling of LBRC membrane are subjects for future study. JEM VOL. 205, April 14, 2008 
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nocodazole, or DMSO (control) at the concentration used to dissolve each 
drug (always   <  0.05%). Cells were then rinsed in prewarmed divalent cat-
ion  –  containing PBS and fi  xed for 1 min in cold (    80  °  C) methanol. In some 
experiments, cell monolayers were permeabilized by exposure to saponin 
before fi  xation to allow extraction of soluble tubulin. In these experiments, 
cells were washed in PEM buff  er (100 mM Pipes, 5 mM EGTA, 5 mM 
MgCl  2  , pH 8.6) and exposed for 45 s to 0.3 mg/ml saponin in PEM, fol-
lowed by washes in PEM before methanol fi  xation. Microtubules were vi-
sualized by indirect immunostaining using a mouse anti  –      -tubulin antibody 
detected by an Alexa Fluor 546  –  rabbit anti  –  mouse antibody. In some exper-
iments, mitochondria were stained using Mitotracker (Invitrogen) by incu-
bation at 1   μ  M for 30 min at 37  °  C. Intermediate fi  laments were labeled with 
56B5 mouse antivimentin IgM (a gift from Ron Liem, Columbia Univer-
sity, New York, NY), followed by FITC  –  anti  –  Mouse IgM. The endoplas-
mic reticulum was imaged using ER tracker (Invitrogen). Junctions were 
visualized by directly conjugated Alexa Fluor 488  –  hec1 for VE-cadherin or 
Alexa Fluor 488  –  P1.1 for PECAM. 
  To quantitatively analyze the cell-surface expression of PECAM in the 
presence and absence of microtubule depolymerization, HUVEC mono-
layers treated with DCN or DMSO were incubated with Alexa Fluor 546  –
  conjugated anti-PECAM mAb (clone P1.1) or nonspecifi  c control antibody 
conjugated to the same fl  uorophore for 1 h at 37  °  C to saturate the cell bor-
der and LBRC compartments, and were then washed and resuspended by 
incubation in 10   μ  M EDTA in HBSS at 37  °  C. Reuspended cells were 
washed in HBSS, fi  xed in paraformaldehyde, and analyzed on a fl  ow cytom-
eter (FACSCalibur) using CellQuest software (both from BD Biosciences). 
  Permeability assay.     HUVEC monolayers on collagen gels were treated 
with 10   μ  M DCN or DMSO (control), as for the transmigration assay (see 
the following section), and incubated with Alexa Fluor 546  –  conjugated al-
bumin (Invitrogen) at 20   μ  g/ml in culture medium for 1 h at 37  °  C. Mono-
layers were washed, and fl  uorescence was read in a fl  uorescence plate reader 
(CytoFluor 2350; PerSeptive Biosystems). 
  Quantitative TEM assay.     This assay was performed and quantifi  ed as pre-
viously described (  5  ). In brief, PBMCs from healthy volunteers were puri-
fi  ed on a Ficoll density gradient. They were then washed in HBSS plus 0.1% 
human serum albumin and resuspended in M199 plus 0.1% human serum 
albumin. 2   ×   10  5   cells were added to each replicate well of confl  uent mono-
layers of HUVECs grown on hydrated collagen gels and incubated for 1 h at 
37  °  C in a CO  2   incubator. Transmigration assays were performed using both 
  “  resting  ”   and TNF-      –  activated HUVECs. In some experiments, the assay 
was performed using polyclonally stimulated human T cells on TNF-      –  acti-
vated HUVECs with 200 ng/ml of stromal cell  –  derived factor 1 added to 
the collagen 20 min before addition of the lymphocytes. 
  To assess the role of microtubules on monocyte TEM, HUVEC mono-
layers were pretreated with DMSO (control), 10   μ  M DCN, 2   μ  M no-
codazole, or 10   μ  M taxol at 37  °  C for 1 h. They were subsequently washed 
extensively with cold divalent cation  –  containing PBS plus 0.1% human 
  serum albumin before adding PBMCs on top. Monocytes were allowed to 
transmigrate for 1 h (unless otherwise stated in the fi  gure legends). Transmi-
gration was arrested by washing with cold PBS to remove nonadherent cells, 
followed by an overnight fi  xation with 2.5% glutaraldehyde in 0.1 M so-
dium cacodylate buff  er, pH 7.4. Monocyte TEM was quantitated using 
  Nomarski optics, as described previously (  5  ). Typically, we score all of the 
leukocytes in each of several random fi  elds for each monolayer until at least 
100 leukocytes have been counted, with six replicate monolayers for each 
condition. Therefore, in each experiment, data for each condition are de-
rived from interactions of   >  600 leukocytes with six diff  erent monolayers. 
Transmigration data are expressed as the percentage of total monocytes asso-
ciated with the HUVEC monolayer that crossed the endothelial monolayer. 
  Eluate control.     In experiments designed to study the eff  ect of depolymer-
ization of endothelial cell microtubules on TEM, an eluate control was per-
formed to test for an eff  ect of residual drugs on monocytes. In these 
might create a haptotactic gradient for the leukocyte to follow 
through the junction (  9  ). 
  The signifi  cance of our observations extends beyond 
PECAM. Our data show that targeted recycling of membrane 
from the LBRC is required for transmigration. Polyclonally 
activated lymphocytes, whose TEM cannot be blocked by 
anti-PECAM antibody, still require the LBRC for transmi-
gration, because disruption of microtubules blocked TEM to 
the same extent to which it blocked TEM of PECAM-sensitive 
monocytes (  Fig. 6  ). Although many transmigration events in 
vivo require PECAM (  1  ), there are clearly infl  ammatory situ-
ations that are PECAM independent (  25, 42  ). Many of the 
PECAM-independent infl  ammatory conditions involve leu-
kocytes that have been directly stimulated by application of 
exogenous chemokines. We hypothesize that in these situa-
tions other adhesion molecule interactions and/or signals from 
leukocyte to endothelium serve to recruit membrane from 
the LBRC to the zone of diapedesis, substituting for the role 
otherwise played by PECAM. 
  To our knowledge, this is the fi  rst demonstration of a role 
for endothelial microtubules and microtubule motors in dia-
pedesis. The next challenges will be to study microtubule dy-
namics in endothelial cells during TEM, to determine which 
of the many kinesins expressed by endothelium are responsible 
for targeted recycling, and to determine whether they would 
make reasonable antiinfl  ammatory therapeutic targets. 
  MATERIALS AND METHODS 
  Reagents.     hec1 (anti  –  VE-cadherin), P1.1 (anti-CD31), hec7 (anti-CD31), 
and OKM-1 (anti-CD11b), as previously described (  9  ), were fl  uorescently 
labeled with Alexa Fluor 488 or Alexa Fluor 546 according to the manufac-
turer  ’  s instruction (Invitrogen). Unlabeled and rhodamine-conjugated goat 
anti  –  mouse F(ab    )  2   antibodies used for PECAM recycling experiments pur-
chased from Jackson ImmunoResearch Laboratories. Anti  –      -tubulin anti-
body was purchased from Accurate Chemical. Goat anti  –  mouse secondary 
antibodies conjugated to either Alexa Fluor 546 or Alexa Fluor 488 were 
purchased from Invitrogen. DCN was purchased from EMD. Nocodazole, 
taxol, and diaminobenzidine were purchased from Sigma-Aldrich. 
  Cell culture.     HUVECs were isolated from fresh umbilical cords, as previ-
ously described (  3  ), and grown in medium 199 (M199; Invitrogen) supple-
mented with 20% adult human serum and 100 U/ml penicillin  –  streptomycin 
at 37  °  C in a humidifi  ed atmosphere of 5% CO  2.   Experiments were done 
routinely with cells at passage two plated on thick hydrated type I collagen 
gels in 96-well culture plates, or on glass coverslip dishes (Carolina Biologi-
cal Supply) coated with 5   μ  g/ml fi  bronectin (Sigma-Aldrich). In some ex-
periments, endothelial cells were activated by incubation with 10 ng/ml 
TNF-     for   ≥  4 h before the addition of leukocytes. 
  PBMCs were isolated from healthy volunteers by density gradient cen-
trifugation in Ficoll-Paque, as previously described (  43  ). In some experi-
ments, T cells were isolated from this mixture by adhesion of monocytes to 
a 100-mm tissue culture plate. Nonadherent T cells were removed and cul-
tured in RPMI 1640 (Invitrogen) supplemented with 10% fetal bovine se-
rum, 100 U/ml penicillin  –  streptomycin, and 1   μ  g/ml PHA for 3 d, followed 
by culture in 20 ng/ml IL-2 for 3  –  6 d (  30  ). All experimental protocols were 
approved by the Weill Cornell Medical College Institutional Review Board. 
  Immunofl  uorescence.     To visualize the eff  ects of treatments on micro-
tubules, HUVEC monolayers were incubated for 1 h at 37  °  C in M199 con-
taining 0.1 human serum albumin plus 10   μ  M DCN, 10   μ  M taxol, 2   μ  M 964 LEUKOCYTE TRANSMIGRATION REQUIRES LBRC TRAFFICKING | Mamdouh et al.
same buff  er without Fluo3 or pluronic acid for 20 min at room temperature 
to allow hydrolysis of the dye ester. The culture dishes were then placed on 
a heated microscope stage. Fluorescent images were acquired every 5 s before 
and after the addition of 10   μ  M histamine. Quantitative analysis of the images 
was performed with MetaMorph software. In brief, after background sub-
traction, the averaged intensity per fi  eld was measured for each time point, 
and the relative intensities per fi  eld for each time point were plotted. 
  Immuno-EM.     Horseradish peroxidase (HRP) was conjugated to P1.1 IgG, 
as previously described. (  9  ). HUVEC monolayers plated on fi  bronectin-
coated coverslip dishes were fi  rst loaded with HRP-P1.1 mAb directed 
against PECAM, and then exposed to control vehicle or 10   μ  M DCN for 1 h 
at 37  °  C in the presence of HRP-P1.1 mAb. They were subsequently rinsed 
in cold PBS and fi  xed in 4% glutaraldehyde (EM Sciences) in 0.1 M sodium 
cacodylate buff  er for 15 min. Cells were rinsed, and a mixture of diamino-
benzidine and H  2  O  2   was added to the cells to visualize PECAM staining ac-
cording to the method of Graham and Karnovsky (  44  ). The cells were 
postfi  xed in 4% glutaraledehyde and embedded in plastic, and en face sections 
were cut and examined on an electron microscope (JSM 100CX II; JEOL). 
  Stereologic analysis.     Electron micrographs of representative randomly se-
lected en face sections from HUVEC monolayers incubated at 37  °  C with 
HRP-P1.1 in the presence or absence of DCN were opened in Photoshop 
(Adobe) and overlaid with grids. Quantitation was performed as previously 
described (  9  ) by standard stereologic techniques. In brief, the number of 
times the random lines crossed DAB-labeled internal membrane compart-
ments or junctional membrane were recorded. The ratio is proportional to 
their relative surface area. 
  Microinjection of endothelial cells.     HUVECs grown to confl  uence on 
coverslip dishes were incubated with TNF-     for at least 4 h, during which 
time they were pressure microinjected with HD IgG (anti-kinesin motor 
domain) or purifi  ed nonimmune rabbit IgG prepared in HKCl (10 mM 
Hepes, 140 mM KCl, pH 7.4) at a concentration of 20 mg/ml using a 
micromanipulator (MMN-1; Narishige), as previously described (  45  ). The 
control IgG serves as a control for nonspecifi  c damage to the cells caused by 
the volume of material injected and the presence of a high concentration of 
exogenous protein. After injection, cells were maintained at 37  °  C for 1 h 
before any manipulations involving antibody (e.g., for targeted recycling ex-
periments), and 3 h before addition of leukocytes in the continued presence 
of TNF-    . 
  Statistics.     All data were analyzed by pairwise comparison using a two-tailed 
  t   test assuming unequal variances, with the Bonferroni correction for multi-
ple comparisons as appropriate. 
  Online supplemental material.     Fig. S1 demonstrates that nocodazole de-
polymerizes microtubules without disrupting endothelial cell junctions. Fig. S2 
shows that taxol treatment of HUVECs induces bundling and stabilization 
of microtubules without disrupting endothelial borders. Fig. S3 shows 
that microtubule stabilization by taxol and actin fi  lament stabilization by 
jasplakinolide do not aff  ect monocyte adhesion, but taxol selectively blocks 
TEM. Fig. S4 shows that taxol does not aff  ect constitutive recycling of 
membrane from the LBRC. Fig. S5 shows that the DCN treatment used in 
our experiments does not result in redistribution of mitochondria, endoplas-
mic reticulum, or calcium fl  ux in response to histamine in the treated endo-
thelial cells, and that microinjection of control and HD antibody do not 
aff  ect the distribution of intermediate fi  laments. Fig. S6 demonstrates that 
the anti-kinesin motor domain antibody used in our experiments, but not 
control IgG, prevents centrifugal redistribution of mitochondria along mi-
crotubules. Fig. S7 shows that microinjection of control IgG does not aff  ect 
the expression or distribution of PECAM or ICAM-1 in HUVEC mono-
layers. Table S1 lists the kinesin family members expressed in our cultured 
HUVECs. Online supplemental material is available at http://www.jem
.org/cgi/content/full/jem.20072328/DC1. 
experiments, replicate HUVEC monolayers were subjected to the same con-
ditions as those undergoing treatment with depolymerizing agents. Fresh 
culture medium was added, and these monolayers were returned to the in-
cubator for 1 h (or whatever the length of the experiment). The conditioned 
medium, containing whatever drug had eluted during that time, was col-
lected from these monolayers. PBMCs in the eluate control were resus-
pended directly in this medium and added to untreated HUVEC monolayers. 
The leukocytes of the eluate control were thus exposed at time zero to all of 
the drug that would have eluted over the time course of the experiment. 
  Endothelial microtubule disruption and PECAM recycling.     Recy-
cling experiments were performed as previously described (  9  ). In brief, 
  HUVEC monolayers were incubated in the presence of an Fab fragment of 
P1.1 mAb for 1 h at 37  °  C. This mAb binds to PECAM domain fi  ve and does 
not block any known PECAM function. It serves as a marker for PECAM 
in the cell. HUVECs were then chilled and washed of free antibody, and an 
excess of an F(ab    )  2   fragment of unlabeled goat anti  –  mouse IgG was added to 
the cells. After 1 h of incubation on ice, unbound antibody was washed away, 
and a rhodamine-conjugated F(ab    )  2   fragment of the same goat anti  –  mouse 
antibody was premixed with incubation medium containing either 10   μ  M 
DCN or DMSO at the concentration used to dissolve DCN. After 1 h of 
incubation on ice, cells were placed at 37  °  C and incubated for diff  erent time 
periods, as shown in the fi  gures. Cells were chilled, washed, and fi  xed in 
freshly prepared 2% paraformaldehyde for 10 min at room temperature. 
  In experiments to measure the eff  ect of microtubule or actin fi  lament 
perturbation on recycling of PECAM, HUVEC monolayers were incubated 
with Fab P1.1 antibody for 1 h at 37  °  C, and 10   μ  M DCN, 10   μ  M taxol, 
2   μ  M nocodazole, 400 nM jasplakinolide, or DMSO at the concentration 
used to dissolve each of the drugs used was added to the P1.1-containing incuba-
tion medium. After 1 h of incubation at 37  °  C, cells were chilled and washed, 
and the remaining steps of the recycling experiment were performed as de-
scribed in the presence or absence of each drug. 
  In experiments to examine targeted recycling of membrane from the 
LBRC during diapedesis, the monolayers were prepared as described in this 
section. Purifi   ed leukocytes were resuspended in the rhodamine-labeled 
F(ab    )  2   secondary antibody and allowed to settle on top of the HUVEC 
monolayers on ice. When the monolayers were returned to 37  °  C, transmi-
gration and recycling resumed. The co-cultures were washed and fi  xed as 
described in this section. 
  Microscopy and image processing.     Fluorescence microscopy was per-
formed on a confocal microscope (LSM510; Carl Zeiss, Inc.) using a 63   ×   1.4 
numerical aperture oil immersion objective, or on an epifl  uorescence micro-
scope (Axiovert; Carl Zeiss, Inc.) with a cooled charge-coupled device 12-bit 
camera (Princeton Instruments) using a 25   ×   1.25 numerical aperture oil im-
mersion objective. Image processing and quantifi  cation were performed using 
image processing software (MetaMorph; MDS Analytical Technologies). 
  Quantifi   cation of targeted recycling.     Images were processed using 
MetaMorph. Background corrected images were highlighted in pseudo-
color, and a one-pixel-wide line (narrower than the width of the junction) 
was drawn along the junctions that surround the site of diapedesis and across 
the brightest pixels of the ring of recycled PECAM. Intensities at the selected 
areas were generated by the software. We calculated the maximum PECAM 
enrichment by dividing the highest fl  uorescence intensity determined at the 
ring by the average intensity obtained at the junctions in the vicinity of the 
ring. The levels of recycling PECAM fl  uorescence away from the areas of 
leukocyte contact were found empirically to be the same in control and 
DCN-treated cells (  Fig. 3 C  ). 
  Calcium fl  ux assay.     HUVEC monolayers were treated with 10   μ  M DCN 
or DMSO (control) for 1 h at 37  °  C, and then washed and incubated in the 
dark for 30 min at 37  °  C with 10   μ  M Fluo3/AM (Invitrogen) in M199 con-
taining 0.025% pluronic acid, 2.5 mM probenecid, 0.5% human serum albumin, 
and 20 mM Hepes. The monolayers were washed twice and incubated in the JEM VOL. 205, April 14, 2008 
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